Home Media Press Release Framatome and NRG sign contracts for fuel supply and medical radioisotope targets
Press Release

Framatome and NRG sign contracts for fuel supply and medical radioisotope targets

December 07, 2022 | 1 min |
Topic: fuelmedical

December 7, 2022 – Framatome signed two contracts with NRG to supply enriched uranium targets and fuel elements for the High Flux Reactor (HFR) in the Netherlands. The HFR research reactor produces more than 60% of Europe’s medical isotopes, primarily for the use in diagnostic nuclear imaging scans. 

“We are pleased to continue our long partnership with NRG and to contribute to the accessibility of critical medical radioisotopes worldwide,” said François Gauché, director of Framatome Healthcare and vice president of CERCA of the Fuel Business Unit at Framatome. “With more than 40 million nuclear medicine procedures performed worldwide each year, we are proud to be a key supplier of fuel for research reactors to help meet this critical demand.”

These new contracts call for a multi-year supply of fuel elements for the HFR and of uranium targets to produce the radioisotope Mo-99 among others. The fuel will come from the Framatome CERCA fuel manufacturing facility in Romans, France. For more than 60 years CERCA has been producing nuclear fuel and uranium targets for research reactors.

NRG has been a Framatome customer for more than two decades and this strong partnership was key in finalizing these agreements. Framatome is committed to support NRG in the continuous safe and efficient operation of the HFR reactor for the benefits of the scientific and nuclear medicine communities.

NRG research reactor

The High Flux Reactor (HFR) in the Netherlands


About Framatome

Framatome is an international leader in nuclear energy recognized for its innovative, digital and value added solutions for the global nuclear fleet. With worldwide expertise and a proven track record for reliability and performance, the company designs, services and installs components, fuel, and instrumentation and control systems for nuclear power plants. Its more than 16,000 employees work every day to help Framatome’s customers supply ever cleaner, safer and more economical low-carbon energy.

Framatome is owned by the EDF Group (75.5%), Mitsubishi Heavy Industries (MHI – 19.5%) and Assystem (5%).